Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: N/E PATSFAN who wrote (7618)	5/5/1998 2:16:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 9262

NEPF: AFFX..... I'm leaving it alone, as (1) a powerhouse, INCY, is treading on their territory, and (2) there are less expensive routes to end products that will give the same answers. OncorMed..... I worked briefly with the CEO, Triche, while he was at Children's and I was at PharMingen. Very bright guy, but I was surprised to see the transition directly from academics to CEO. I don't follow them closely, but make sure that the patent problems for Oncor don't spill over to taint them??? So, no opinion, other than to say that any products may have issues with slow market penetration. VMRX..... yes, it'll be dead until it's not. But, I'm second guessing...... let's not focus here. Rick